Ignite Creation Date:
2025-12-24 @ 3:07 PM
Ignite Modification Date:
2026-01-25 @ 7:17 AM
Study NCT ID:
NCT02579759
Status:
COMPLETED
Last Update Posted:
2020-02-27
First Post:
2015-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Sponsor:
Pharnext S.C.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-28
First Submit QC Date:
None
Study First Post Date:
2015-10-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-11-18
Results First Submit QC Date:
None
Results First Post Date:
2020-02-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-13
Last Update Post Date:
2020-02-27
Last Update Post Date Type:
ACTUAL